Jiangsu Lianhuan Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Jiangsu Lianhuan Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Jiangsu Lianhuan Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Net change in cash272,386,1810.1001642015-06-30historic
Selling expenses109,046,3550.04007722015-06-30historic
Net cashflow from financing activities283,231,4700.104091222015-06-30historic
Investment income from associate and joint venture2,785,3880.001021532015-06-30historic
Fair value change gain-2,8400.01952015-06-30historic
Other current liabilities2,507,9259.2E-42332015-06-30historic
Net cash and cash equivalents ending balance377,811,7410.138842482015-06-30historic
Cash paid for taxes45,231,9110.016623212015-06-30historic
Long term equity investment38,359,5070.01413322015-06-30historic
Other receivables29,852,6650.010973382015-06-30historic
Notes receivable38,265,4210.014063472015-06-30historic
Cash inflows from financing activities385,929,9960.141833682015-06-30historic
Cash paid for other financing activities4,001,0000.001474042015-06-30historic
Capital reserve374,046,2740.137464372015-06-30historic
Prepayment32,269,5850.011865052015-06-30historic
Purchases of fixed assets and others26,528,2120.009755192015-06-30historic
Proceeds from sell of investment211,9008.0E-55512015-06-30historic
Operating profit28,997,8250.010665662015-06-30historic
Short term borrowings105,500,0000.038776112015-06-30historic
Net income23,792,6050.008746152015-06-30historic
Total profit28,775,8920.010586162015-06-30historic
Total comprehensive income23,792,6050.008746272015-06-30historic
Interests payable208,9798.0E-56322015-06-30historic
Total cost of goods sold302,134,4370.111036332015-06-30historic
Revenue328,321,0870.120666392015-06-30historic
Cash paid for dividends, profits or interests17,197,5260.006326432015-06-30historic
Comprehensive income attributable to minority shareholders-8,3210.06552015-06-30historic
Net cash flows from investing activities-25,506,312-0.009376642015-06-30historic
Minority interests gain-8,3210.06672015-06-30historic
Non-operating loss221,9328.0E-56762015-06-30historic
Cash inflows from operating activities303,446,2510.111526852015-06-30historic
Cash outflows from operating activities288,715,6910.10616972015-06-30historic
Financial expenses2,696,2529.9E-47032015-06-30historic
Deferred tax assets4,664,4620.001717352015-06-30historic
Fixed assets174,033,1270.063967372015-06-30historic
Payroll payable4,164,9410.001537922015-06-30historic
Total liabilities and equity952,187,2620.349928422015-06-30historic
Other payables11,395,1150.004198552015-06-30historic
Accounts payable51,883,9590.019078702015-06-30historic
Total non-current assets243,793,6380.089599832015-06-30historic
Total liabilities204,032,5440.0749810132015-06-30historic
Inventories54,388,2350.0199910142015-06-30historic
Other current assets338,6241.2E-410342015-06-30historic
Minority interest319,4731.2E-410452015-06-30historic
Intangible assets4,629,3920.001712162015-06-30historic